Close Menu

NEW YORK (GenomeWeb) — Agendia said today that it has raised $35 million in a deal with healthcare investment firm Athyrium Capital Management.

As part of the deal, Athyrium will receive a non-executive director seat on Agendia's board.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.